Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Pfizer (NY: PFE )

25.53 -0.11 (-0.43%)
Official Closing Price Updated: 7:00 PM EST, Feb 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 33,214,751
Open 25.73
Bid (Size) 25.72 (6)
Ask (Size) 25.76 (32)
Prev. Close 25.64
Today's Range 25.47 - 25.83
52wk Range 24.48 - 31.54
Shares Outstanding 5,606,688,356
Dividend Yield 6.58%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Pfizer's Talzenna/Xtandi Combo Improves Survival Outcomes In Metastatic Castration-Resistant Prostate Cancer
Pfizer's TALAPRO-2 study shows Talzenna + Xtandi significantly improves survival in mCRPC patients, with up to a 14-month OS gain in HRR-mutated cases. 
Via Benzinga
Robert F. Kennedy, Vaccine Skeptic, Confirmed As Trump's Secretary Of Health: Health Care Stocks To Watch
The U.S. Senate voted on Thursday to confirm President Donald Trump's nomination of Robert F. Kennedy Jr. to lead the Department of Health and Human Services. 
Via Benzinga
Topics Government
Exposures Political

Performance

YTD
-4.06%
-4.06%
1 Month
-3.62%
-3.62%
3 Month
+2.70%
+2.70%
6 Month
-11.35%
-11.35%
1 Year
-7.57%
-7.57%

More News

Read More
Pfizer’s TALZENNA® in Combination with XTANDI® Improves Survival Outcomes in Metastatic Castration Resistant Prostate Cancer
From Pfizer Inc.
Via Business Wire
Are Investors Being Too Paranoid About Pfizer Stock?
Via The Motley Fool
Pfizer's Options Frenzy: What You Need to Know
Via Benzinga
Is Now a Good Time to Buy the Dip on Pfizer?
Via The Motley Fool
Zoetis (NYSE:ZTS) Posts Q4 Sales In Line With Estimates But Stock Drops
Via StockStory
3 Brand-Name, Ultra-High-Yield Dividend Stocks Patient Investors Can Confidently Buy With $300 Right Now
Via The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
U.S. FDA Approves Pfizer’s ADCETRIS® Combination Regimen for the treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma
From Pfizer Inc.
Via Business Wire
Earnings To Watch: Zoetis (ZTS) Reports Q4 Results Tomorrow
Via StockStory
Organon (OGN) Q4 Earnings Report Preview: What To Look For
Via StockStory
Pfizer/Astellas Tout Encouraging Data From Keytruda Combo Regime In Urothelial Cancer Showing 49% Reduction In Death Risk Vs. Chemo
Via Benzinga
Pfizer and Astellas’ PADCEV® (enfortumab vedotin-ejfv) plus KEYTRUDA® (pembrolizumab) Shows Long-Term Efficacy in First-Line Treatment of Locally Advanced or Metastatic Urothelial Cancer (la/mUC)
From Pfizer Inc.
Via Business Wire
Explore the S&P500 index on Monday and find out which stocks are the most active in today's session.
Via Chartmill
Super Bowl Commercials 2025: Complete List of Super Bowl LIX Ads And Companies Behind Them
Via Benzinga
These Stocks Missed on Earnings, But Will Rebound Next Quarter
Via MarketBeat
Royalty Pharma Earnings: What To Look For From RPRX
Via StockStory
Better High-Yield Dividend Stock: Pfizer vs. Merck
Via The Motley Fool
3 No-Brainer Healthcare Stocks to Buy With $200 Right Now
Via The Motley Fool
3 Dividend Stocks to Double Up on Right Now
Via The Motley Fool
10 Undervalued Hidden Gem Dividend Stocks For Savvy Investors
Via Talk Markets
Topics Stocks / Equities
Most active S&P500 stocks in Thursday's session
Via Chartmill
Arcutis Soared In 2024, Blazing Trails In Dermatology. Why Its CEO Eyes Bigger Gains.
Via Investor's Business Daily
Exposures Product Safety
What Drives Billionaire Masayoshi Son?
Via The Motley Fool
Topics Artificial Intelligence
Exposures Artificial Intelligence
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.